-
High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone.
PMID: 18182586 [PubMed - indexed for MEDLINE]
PMCID: PMC2200846
-